-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Upgrades Artelo Biosciences to Buy, Announces $20 Price Target

Benzinga·07/08/2025 11:12:26
Listen to the news
D. Boral Capital analyst Jason Kolbert upgrades Artelo Biosciences (NASDAQ:ARTL) from Hold to Buy and announces $20 price target.